In contrast, other studies have shown GNAQ and GNA11 mutations are not associated with poor patient outcomes or disease progression in uveal melanoma, which could be due to the mutations being initial steps in the development of melanoma [137,138]. The gene discussed is GNA11; the disease is uveal melanoma.